operative VTE in two groups of patients operated on by two surgeons; one who consistently used he... more operative VTE in two groups of patients operated on by two surgeons; one who consistently used heparin with SCDs (Group 1) and the other who used SCDs alone (Group 2) for prophylaxis. METHODS: An IRB approved prospectively managed database was analyzed. Group 1 received SCDs just prior to induction and 5,000 units of heparin subcutaneously just after induction. SCDs continued postoperatively and heparin was given twice a day until discharge. Group 2 maintained SCDs until ambulatory. VTE rate, patient age, BMI, operative time, lymphocele rate, estimated blood loss, and pathologic stage were compared between the two groups. Categorical variables were analyzed with chi square test of proportions and continuous variables with t-test using SPSS v 14 software. RESULTS: 1,035 consecutive patients underwent robotic prostatectomy between August 1, 2007 and September 30, 2010. 652 patients received heparin/SCDs and 383 received SCDs alone. Patient age, BMI, estimated blood loss, and pathologic stage were the same in the two groups. There was one lymphocele in each group. Although operative times were longer in Group 2 (228.0 v 165.4 min, p 0.001), the incidence of VTE was the same (0.8% v 0.8%, p .620). BMI, operative time, EBL, and the performance of lymph node dissection were not associated with VTE. CONCLUSIONS: The risk of VTE in patients undergoing robotic prostatectomy is low and not significantly reduced with the administration of prophylactic heparin/SCDs compared to SCDs alone.
nodes as well as of nodal metastases according to landing zone (namely, obturator, external iliac... more nodes as well as of nodal metastases according to landing zone (namely, obturator, external iliac and hypogastric nodes +/-common iliac nodes). Kaplan-Meier curves assessed CSS rates according to the number of positive landing zone (1 vs ≥2), as well as to the laterality of positive nodes (mono vs bilateral). Multivariable Cox regression models tested the association between number of positive landing sites as well as laterality and CSS after accounting for PSA, number of positive nodes, number of nodes removed, pathological Gleason, and stage. results: Mean age was 65.3 years (median: 65.4; range: 44-83). Mean PSA was 39.4 ng/ml (median 14; range 0.9-350 ng/ml). Overall, the mean number of nodes removed was 20.5 (median:19; range: 5-63) while the mean number of positive nodes was 5.5 (median: 3; range:2-59). Mean follow-up was 55.3 months (median 45; range 6-199). Overall, 102 (27.4%) pts had 1 single positive landing sites, while the remaining 270 (72.6%) had >1. Of all pts, 242 (65.1%) had bilateral nodal invasion. Prostate CSS rates at 5 and 10 years were 86 and 73%. At Kaplan Meier analysis, no differences in CSS were found between pts with 1 vs >1 positive landing sites at 5 and 10 year follow-up (87 and 75% vs 81 and 73%;p=0.3). Similarly, no differences were found when laterality was considered (p=0.76). These results were confirmed at multivariable analyses where number of positive landing sites and laterality did not show any association with CSS (all p≥0.3). Conversely, number of positive nodes represented the only independent predictor of CSS (all p ≤0.008). Conclusions: This is the first study investigating the impact of number as well as the laterality of positive landing sites on CSS in patients with node positive prostate cancer. We demonstrated that number of positive nodes, regardless their location, represent the only pathological variable associated with survival in this patient category.
Introduction: The goal of the study is to evaluate and report on the third-generation da Vinci su... more Introduction: The goal of the study is to evaluate and report on the third-generation da Vinci surgical (Si) system malfunctions.Methods: A total of 1228 robotic surgeries were performed between January 2012 and December 2015 at our academic centre. All cases were performed by using a single, dual console, four-arm, da Vinci Si robot system. The three specialties included urology, gynecology, and thoracic surgery. Studied outcomes included the robotic surgical error types, immediate consequences, and operative side effects. Error rate trend with time was also examined.Results: Overall robotic malfunctions were documented on the da Vinci Si systems event log in 4.97% (61/1228) of the cases. The most common error was related to pressure sensors in the robotic arms indicating out of limit output. This recoverable fault was noted in 2.04% (25/1228) of cases. Other errors included unrecoverable electronic communication-related in 1.06% (13/1228) of cases, failed encoder error in 0.57% (7...
Introduction: Our aim was to assess adherence to National Comprehensive Cancer Network (NCCN) and... more Introduction: Our aim was to assess adherence to National Comprehensive Cancer Network (NCCN) and American Urological Association (AUA) guidelines for pelvic lymph node dissection (PLND) at the time of either robot-assisted (RARP) or open radical prostatectomy (ORP).Methods: We relied on the Surveillance, Epidemiology, and End Results-Medicare linked database and focused on localized prostate cancer (PCa) patients who were treated with either RARP or ORP between October 2008 and December 2009. Categorical and multivariable logistic regression analyses targeted two endpoints: 1) probability of guideline-recommended PLND; and 2) probability of no PLND, when not guideline-recommended.Results: Among 5268 PCa patients, adherence to NCCN PLND guideline was 56.9% during RARP and 76.5% during ORP (odds ratio [OR] 0.4, 95% confidence interval [CI] 0.3‒0.6). AUA PLND guideline adherence was 68.1% during RARP and 82.4% during ORP (OR 0.7, 95% CI 0.5‒0.9). When PLND was not recommended, it was ...
Current clinicopathologic parameters are insufficient to predict the likelihood of biochemical re... more Current clinicopathologic parameters are insufficient to predict the likelihood of biochemical recurrence in patients with prostate cancer after radical prostatectomy. Such information may help to identify patients who would likely benefit from adjuvant radiotherapy rather than active surveillance. A multiplex proteomic assay, previously tested on biopsies and found to be predictive of favorable or unfavorable pathology at radical prostatectomy, was assessed for its predictive value to identify patients at higher risk of biochemical relapse. Proteomic assays from core needle biopsies from 288 men who subsequently underwent radical prostatectomy at the Centre hospitalier de l'Université de Montréal were evaluated for prediction of subsequent biochemical recurrence. Of the 288 men, biochemical relapse was observed in 47 (16.3%) and metastases in 5 (1.7%). Median follow up was 68.5 months. The proteomic assay clearly separated patients into three categories - low, intermediate and ...
To examine the characteristics of robot-assisted radical prostatectomy (RARP) and open radical pr... more To examine the characteristics of robot-assisted radical prostatectomy (RARP) and open radical prostatectomy (ORP) patients at a high-volume center. We relied on the Martini-Clinic database and focused on prostate cancer patients treated in 2013. Characteristics in ORP and RARP patients were assessed. In multivariable logistic regression analyses (MVA), we predicted RARP treatment. Of 1,920 patients, 575 (29.9%) underwent RARP and 1,345 (70.1%) ORP. RARP patients had a lower prostate-specific antigen (PSA), and were less likely to harbor pT3b, pathological Gleason ≥4 + 4 or lymph node metastases (all p < 0.05). Pelvic lymph node dissection (PLND) (84.3 vs. 87.0%, p = 0.1), as well as positive surgical margins (15.5 vs. 15.7%, p = 0.7) and the nerve-sparing status (p = 0.5) were comparable between RARP and ORP. Lymph node yield (median 11 vs. 16), and median blood loss (250 vs. 700 ml) were lower at RARP (all p < 0.001). Additionally, the median operating room time was higher a...
RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VT... more RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VTE by CRSs. The rates of VTEs and median times to VTE were 6% and 74 days in Group 1, 13% and 44 days in Group 2, 15% and 40 days in Group 3, and 23% and 11 days in Group 4. Adjusted hazard ratios for VTE are shown in Table 1. Group 1 had no VTE’s or fatal pulmonary embolisms in the first 30 days after UOS. Bleeding and lymphocele rates were 0% and 2% in Group 1, 0% and 4% in Group 2, 3% and 3% in Group 3, 0% and 0% in Group 4. Complications were considered Clavien grades II-IIIa. CONCLUSIONS: VTE risk is lowest in patients who receive clinical protocol prophylaxis with EDP. Risk of VTE remains elevated for at least 90 days following UOS. A clinical VTE prevention protocol using perioperative prophylaxis and EDP is effective and safe in reducing VTE risk in UOS patients.
To evaluate the surgical performance of the new Greenlight XPS-180 W laser system (American Medic... more To evaluate the surgical performance of the new Greenlight XPS-180 W laser system (American Medical Systems, Minnetonka, MI) and the effect of prostate volume (PV), in comparison with the former HPS-120 W system, for the treatment of benign prostatic hyperplasia by photo-selective vaporization of the prostate. Between July 2007 and March 2012, 1809 patients underwent laser photo-selective vaporization of the prostate (1187 patients with the use of HPS-120 W and 622 patients with the use of XPS-180 W) at 7 international centers. All data were collected prospectively. Comparative analysis was performed between XPS and HPS according to PV measured by transrectal ultrasound. The XPS compared with HPS, allowed significantly reduced laser and operative time (29.6 minutes vs 65.8 minutes and 53 minutes vs 80 minutes, respectively; P &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt;.01 for both). The number of fiber used during the procedures was significantly reduced with the XPS system (1.11 vs 2.28; P…
Introduction: Transrectal ultrasound (TRUS)-guided prostate biopsies using 18G calibre needles ar... more Introduction: Transrectal ultrasound (TRUS)-guided prostate biopsies using 18G calibre needles are widely used; most often 12-core tissue samples of the peripheral zone are obtained. Although the diagnostic yield of prostate biopsies is fair, there is still a potential for false negative results, which necessitates repeat biopsies. In an effort to improve the accuracy of prostate biopsies, different sampling schemes have been developed. One strategy has been to increase the number of core biopsies performed on each patient. Another strategy has been to improve the reliability of prostate biopsies using larger calibre needles, thereby increasing the amount of tissue obtained for each core biopsy. Methods: After approval by our institutional review board, we prospectively compared two biopsy needle sizes (18G vs. 16G) in relation to prostate cancer diagnosis, pain, bleeding and infection rates on 105 patients. Each patient underwent 6 TRUS-guided prostate biopsies with the standard 18G needle and 6 other biopsies with the experimental 16G needle. To evaluate possible complications related to the use of a larger 16G needle in the experimental group, we compared pain, bleeding and infection rates with a control group of 100 patients who underwent 12 biopsies with a single 18G needle (18G group). Pain, bleeding assessment and infection events were evaluated using patient questionnaires and telephone interviews. Results: TRUS-guided prostate biopsies using 16G calibre needles did not increase cancer detection or non-malignant pathology rate, including prostatic intraepithelial neoplasia (PIN) and atypical small acinar proliferatio (ASAP). Pain, bleeding and infectious complications were similar in both groups. Infection was defined as temperature above 38°C occurring within 48 hours after the procedure. We identified 4 patients with post-biopsy fever in the experimental (16/18G) group and 4 other patients in the (18G) control group. The post-biopsy infection rate is higher than reported just a few years ago and indicates that quinolone resistant Escherichia coli seems to be more prevalent in our urban setting than previously suspected. Limitations to our study include small group numbers. Conclusion: Larger 16G needles appear to be safe for TRUS-guided prostate biopsies. Further study in a larger, multi-institutional, prospective, randomized manner with 16G needles is warranted to assess the theoretical benefit of larger core biopsies in prostate cancer detection.
operative VTE in two groups of patients operated on by two surgeons; one who consistently used he... more operative VTE in two groups of patients operated on by two surgeons; one who consistently used heparin with SCDs (Group 1) and the other who used SCDs alone (Group 2) for prophylaxis. METHODS: An IRB approved prospectively managed database was analyzed. Group 1 received SCDs just prior to induction and 5,000 units of heparin subcutaneously just after induction. SCDs continued postoperatively and heparin was given twice a day until discharge. Group 2 maintained SCDs until ambulatory. VTE rate, patient age, BMI, operative time, lymphocele rate, estimated blood loss, and pathologic stage were compared between the two groups. Categorical variables were analyzed with chi square test of proportions and continuous variables with t-test using SPSS v 14 software. RESULTS: 1,035 consecutive patients underwent robotic prostatectomy between August 1, 2007 and September 30, 2010. 652 patients received heparin/SCDs and 383 received SCDs alone. Patient age, BMI, estimated blood loss, and pathologic stage were the same in the two groups. There was one lymphocele in each group. Although operative times were longer in Group 2 (228.0 v 165.4 min, p 0.001), the incidence of VTE was the same (0.8% v 0.8%, p .620). BMI, operative time, EBL, and the performance of lymph node dissection were not associated with VTE. CONCLUSIONS: The risk of VTE in patients undergoing robotic prostatectomy is low and not significantly reduced with the administration of prophylactic heparin/SCDs compared to SCDs alone.
urine and stone cultures as well as stone analysis for mineral content. A multivariate cumulative... more urine and stone cultures as well as stone analysis for mineral content. A multivariate cumulative logit regression model was used for statistical analysis. RESULTS: A positive correlation between UCx and SCx occurred in 109 cases (79%) and the level of discordance was similar in both the struvite, apatite (36.8% and 34.3%) but less in the non-struvite/ apatite group (24.4%). A positive SCx with negative UCx occurred in 12.5% of patients overall but occurred more commonly in the struvite and apatite groups (4, 21.1% and 5, 14.3%). Of patients presenting with positive UCx and SCx (n¼43), 13 or 30.2% (9.6% overall) had different organisms between the UCx and SCx. UCx showed no association with stone mineral content, but SCx was more frequently positive in struvite (84.2%) and apatite (65.7%) compared to non-struvite/apatite (25.6%) stones. There was not a significant correlation between stone composition and bacterial species in either UCx or SCx, there was however a 100%, 73% and 33% correlation between UCx and SCx for Enterococcus, Proteus and E.Coli respectively. CONCLUSIONS: Nearly a quarter of our patients had a positive stone culture after sterile urine or a different organism comparing stone to urine culture. When treating these infections a stone culture is essential to accurate microbial identification and antibiotic selection. Furthermore, we found that a preoperative urine culture with either enterococcus or proteus was highly predictive of the stone culture, allowing confidence in treating these infections based on UCx alone.
RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VT... more RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VTE by CRSs. The rates of VTEs and median times to VTE were 6% and 74 days in Group 1, 13% and 44 days in Group 2, 15% and 40 days in Group 3, and 23% and 11 days in Group 4. Adjusted hazard ratios for VTE are shown in Table 1. Group 1 had no VTE's or fatal pulmonary embolisms in the first 30 days after UOS. Bleeding and lymphocele rates were 0% and 2% in Group 1, 0% and 4% in Group 2, 3% and 3% in Group 3, 0% and 0% in Group 4. Complications were considered Clavien grades II-IIIa. CONCLUSIONS: VTE risk is lowest in patients who receive clinical protocol prophylaxis with EDP. Risk of VTE remains elevated for at least 90 days following UOS. A clinical VTE prevention protocol using perioperative prophylaxis and EDP is effective and safe in reducing VTE risk in UOS patients. Incidence of thromboembolic events: multivariable Cox model Variable HR 95% CI P-value Prophylaxis 0.007 Group 3 vs. 4 0.49 (0.21-1.15) Group 2 vs. 4 0.43 (0.12-1.50) Group 1 vs. 4 0.20 (0.06-0.70) Surgery 0.50 Neph. vs. Cyst. 0.62 (0.27-1.43) Other vs. Cyst. 1.15 (0.26-5.05) Caprini Score* < 0.001 Per 1 point increase 1.33 (1.18-1.50) HR¼Hazard Ratio, CI¼confidence interval, Cyst.¼cystectomy, Neph.¼Nephrectomy. *Caprini score calculated from weighted risk factors depending on likelihood of a factor causing a VTE, uses risk factors such as age, operating room time, abnormal pulmonary function, cevtral venous access, blood transfusion, previous malignancy, current malignancy, BMI, personal or family history of VTE, and many others.
Background and Purpose: With the aging population, it is becoming increasingly important to ident... more Background and Purpose: With the aging population, it is becoming increasingly important to identify patients at risk for postsurgical complications who might be more suited for conservative treatment. We sought to identify predictors of morbidity after surgical treatment of benign prostatic hyperplasia (BPH) using a large national contemporary population-based cohort. Methods: Relying on the American College of Surgeons National Surgical-Quality Improvement Program (ACS-NSQIP; 2006-2011) database, we evaluated outcomes after transurethral resection of the prostate (TURP), laser vaporization of the prostate (LVP), and laser enucleation of the prostate (LEP). Outcomes included blood-transfusion rates, length of stay, complications, reintervention rates, and perioperative mortality. Multivariable logistic-regression analysis evaluated the predictors of perioperative morbidity and mortality. Results: Overall, 4794 (65.2%), 2439 (33.1%), and 126 (1.7%) patients underwent TURP, LVP, and LEP, respectively. No significant difference in overall complications (P = 0.3) or perioperative mortality (P = 0.5) between the three surgical groups was found. LVP was found to be associated with decreased blood transfusions (odds ratio [OR] = 0.21; P = 0.001), length of stay (OR = 0.12; P < 0.001) and reintervention rates (OR = 0.63; P = 0.02). LEP was found to be associated with decreased prolonged length of stay (OR = 0.35; P = 0.01). Men with advanced age at surgery and non-Caucasians were at increased risk of morbidity and mortality. In contrast, normal preoperative albumin and higher preoperative hematocrit (>30%) levels were the only predictors of lower overall complications and perioperative mortality. Conclusions: All three surgical modalities for BPH management were found to be safe. Advanced age and non-Caucasian race were independent predictors of adverse outcomes after BPH surgery. In patients with these attributes, conservative treatment might be a reasonable alternative. Also, preoperative hematocrit and albumin levels represent reliable predictors of adverse outcomes, suggesting that these markers should be evaluated before BPH surgery.
PURPOSE: Partial nephrectomy (PN) outcomes may be better at academic institutions than at non-aca... more PURPOSE: Partial nephrectomy (PN) outcomes may be better at academic institutions than at non-academic centers. Peer-review, sub-specialized practice profile, higher individual surgeon and institutional caseload may explain this observation. To the best of our knowledge, the role of institutional academic affiliation has not been examined with regard to PN postoperative outcomes. METHODS: Within the Health Care Utilization Project Nationwide Inpatient Sample (NIS), we focused on PNs performed within the 10 most contemporary years (1998-2007). We explored the effect of academic status on three short-term PN outcomes (intraoperative and postoperative complications, as well as in-hospital mortality). Multivariable logistic regression analyses further adjusted for age, race, gender, Charlson Comorbidity Index (CCI), surgical approach, hospital region, annual hospital caseload and insurance status. RESULTS: Overall, 8,513 PNs were identified. Of those, 5,906 (69.4%) were recorded at acad...
OBJECTIVE: Discharge patterns, including prolonged length of stay (LOS) and adverse discharge dis... more OBJECTIVE: Discharge patterns, including prolonged length of stay (LOS) and adverse discharge disposition (ADD), are important clinical indicators of quality of care. We examined the effect of several indicators on discharge patterns after radical prostatectomy (RP). METHODS: Within the Nationwide Inpatient Sample, we focused on RPs performed between 2001 and 2007. Multivariable logistic regression analyses predicting the likelihood of prolonged LOS and ADD were performed. RESULTS: Overall, 89,883 eligible RPs were identified, yielding a weighted national estimate of 442,400 eligible RPs. The rates of prolonged LOS decreased from 28.9 in the early period (2001-2003) to 14.4% in the late period (2006-2007) (P < 0.001). Similarly, the rates of ADD decreased from 7.4 in the early period to 5.0% in the late period (P < 0.001). In multivariable analyses adjusted for clustering, both annual hospital caseload (AHC) and insurance status were independent predictors of prolonged LOS and...
Background: The association of advanced age and cancer control outcomes shows discordant findings... more Background: The association of advanced age and cancer control outcomes shows discordant findings. Objective: To evaluate the effect of age on cancer control outcomes in a large population-based cohort of patients diagnosed with renal cell carcinoma (RCC) of all stages. Design, setting, and participants: Using the Surveillance Epidemiology and End Results database, 36 333 patients with RCC were identified. The population was stratified according to age: < 50, 50-59, 60-69, 70-79, and 80 yr. The effect of age on cancer control outcomes was evaluated using competing-risks regression models. Analyses were repeated stage for stage and grade for grade. Measurements: Cancer-specific mortality (CSM) was measured. Results and limitations: Age categories 50-59, 60-69, 70-79, and 80 yr respectively portended a 1.4-, 1.5-, 1.6-, and 1.9-fold higher risk of CSM than age category <50 yr (all p < 0.001). The effect of advanced age was particularly detrimental in patients with stage I disease: 1.8-, 2.3-, 3.2-, and 3.8-fold higher CSM risk for the same age groups, respectively (all p < 0.001). The effect of age on CSM was at its peak in patients with stage I, low-grade RCC (1.6-, 2.2-, 3.6-, and 4.3-fold, respectively; all p < 0.001) and remained elevated in stage I, high-grade RCC (2.2-, 2.6-, 2.4-, and 3.0-fold higher, respectively; all p < 0.05). Conversely, its effect was virtually absent in patients with stage II-IV RCC. Conclusions: Our data suggest that stage I RCC may behave in a more aggressive fashion in elderly patients. Further studies are required to confirm the current findings.
operative VTE in two groups of patients operated on by two surgeons; one who consistently used he... more operative VTE in two groups of patients operated on by two surgeons; one who consistently used heparin with SCDs (Group 1) and the other who used SCDs alone (Group 2) for prophylaxis. METHODS: An IRB approved prospectively managed database was analyzed. Group 1 received SCDs just prior to induction and 5,000 units of heparin subcutaneously just after induction. SCDs continued postoperatively and heparin was given twice a day until discharge. Group 2 maintained SCDs until ambulatory. VTE rate, patient age, BMI, operative time, lymphocele rate, estimated blood loss, and pathologic stage were compared between the two groups. Categorical variables were analyzed with chi square test of proportions and continuous variables with t-test using SPSS v 14 software. RESULTS: 1,035 consecutive patients underwent robotic prostatectomy between August 1, 2007 and September 30, 2010. 652 patients received heparin/SCDs and 383 received SCDs alone. Patient age, BMI, estimated blood loss, and pathologic stage were the same in the two groups. There was one lymphocele in each group. Although operative times were longer in Group 2 (228.0 v 165.4 min, p 0.001), the incidence of VTE was the same (0.8% v 0.8%, p .620). BMI, operative time, EBL, and the performance of lymph node dissection were not associated with VTE. CONCLUSIONS: The risk of VTE in patients undergoing robotic prostatectomy is low and not significantly reduced with the administration of prophylactic heparin/SCDs compared to SCDs alone.
nodes as well as of nodal metastases according to landing zone (namely, obturator, external iliac... more nodes as well as of nodal metastases according to landing zone (namely, obturator, external iliac and hypogastric nodes +/-common iliac nodes). Kaplan-Meier curves assessed CSS rates according to the number of positive landing zone (1 vs ≥2), as well as to the laterality of positive nodes (mono vs bilateral). Multivariable Cox regression models tested the association between number of positive landing sites as well as laterality and CSS after accounting for PSA, number of positive nodes, number of nodes removed, pathological Gleason, and stage. results: Mean age was 65.3 years (median: 65.4; range: 44-83). Mean PSA was 39.4 ng/ml (median 14; range 0.9-350 ng/ml). Overall, the mean number of nodes removed was 20.5 (median:19; range: 5-63) while the mean number of positive nodes was 5.5 (median: 3; range:2-59). Mean follow-up was 55.3 months (median 45; range 6-199). Overall, 102 (27.4%) pts had 1 single positive landing sites, while the remaining 270 (72.6%) had >1. Of all pts, 242 (65.1%) had bilateral nodal invasion. Prostate CSS rates at 5 and 10 years were 86 and 73%. At Kaplan Meier analysis, no differences in CSS were found between pts with 1 vs >1 positive landing sites at 5 and 10 year follow-up (87 and 75% vs 81 and 73%;p=0.3). Similarly, no differences were found when laterality was considered (p=0.76). These results were confirmed at multivariable analyses where number of positive landing sites and laterality did not show any association with CSS (all p≥0.3). Conversely, number of positive nodes represented the only independent predictor of CSS (all p ≤0.008). Conclusions: This is the first study investigating the impact of number as well as the laterality of positive landing sites on CSS in patients with node positive prostate cancer. We demonstrated that number of positive nodes, regardless their location, represent the only pathological variable associated with survival in this patient category.
Introduction: The goal of the study is to evaluate and report on the third-generation da Vinci su... more Introduction: The goal of the study is to evaluate and report on the third-generation da Vinci surgical (Si) system malfunctions.Methods: A total of 1228 robotic surgeries were performed between January 2012 and December 2015 at our academic centre. All cases were performed by using a single, dual console, four-arm, da Vinci Si robot system. The three specialties included urology, gynecology, and thoracic surgery. Studied outcomes included the robotic surgical error types, immediate consequences, and operative side effects. Error rate trend with time was also examined.Results: Overall robotic malfunctions were documented on the da Vinci Si systems event log in 4.97% (61/1228) of the cases. The most common error was related to pressure sensors in the robotic arms indicating out of limit output. This recoverable fault was noted in 2.04% (25/1228) of cases. Other errors included unrecoverable electronic communication-related in 1.06% (13/1228) of cases, failed encoder error in 0.57% (7...
Introduction: Our aim was to assess adherence to National Comprehensive Cancer Network (NCCN) and... more Introduction: Our aim was to assess adherence to National Comprehensive Cancer Network (NCCN) and American Urological Association (AUA) guidelines for pelvic lymph node dissection (PLND) at the time of either robot-assisted (RARP) or open radical prostatectomy (ORP).Methods: We relied on the Surveillance, Epidemiology, and End Results-Medicare linked database and focused on localized prostate cancer (PCa) patients who were treated with either RARP or ORP between October 2008 and December 2009. Categorical and multivariable logistic regression analyses targeted two endpoints: 1) probability of guideline-recommended PLND; and 2) probability of no PLND, when not guideline-recommended.Results: Among 5268 PCa patients, adherence to NCCN PLND guideline was 56.9% during RARP and 76.5% during ORP (odds ratio [OR] 0.4, 95% confidence interval [CI] 0.3‒0.6). AUA PLND guideline adherence was 68.1% during RARP and 82.4% during ORP (OR 0.7, 95% CI 0.5‒0.9). When PLND was not recommended, it was ...
Current clinicopathologic parameters are insufficient to predict the likelihood of biochemical re... more Current clinicopathologic parameters are insufficient to predict the likelihood of biochemical recurrence in patients with prostate cancer after radical prostatectomy. Such information may help to identify patients who would likely benefit from adjuvant radiotherapy rather than active surveillance. A multiplex proteomic assay, previously tested on biopsies and found to be predictive of favorable or unfavorable pathology at radical prostatectomy, was assessed for its predictive value to identify patients at higher risk of biochemical relapse. Proteomic assays from core needle biopsies from 288 men who subsequently underwent radical prostatectomy at the Centre hospitalier de l'Université de Montréal were evaluated for prediction of subsequent biochemical recurrence. Of the 288 men, biochemical relapse was observed in 47 (16.3%) and metastases in 5 (1.7%). Median follow up was 68.5 months. The proteomic assay clearly separated patients into three categories - low, intermediate and ...
To examine the characteristics of robot-assisted radical prostatectomy (RARP) and open radical pr... more To examine the characteristics of robot-assisted radical prostatectomy (RARP) and open radical prostatectomy (ORP) patients at a high-volume center. We relied on the Martini-Clinic database and focused on prostate cancer patients treated in 2013. Characteristics in ORP and RARP patients were assessed. In multivariable logistic regression analyses (MVA), we predicted RARP treatment. Of 1,920 patients, 575 (29.9%) underwent RARP and 1,345 (70.1%) ORP. RARP patients had a lower prostate-specific antigen (PSA), and were less likely to harbor pT3b, pathological Gleason ≥4 + 4 or lymph node metastases (all p < 0.05). Pelvic lymph node dissection (PLND) (84.3 vs. 87.0%, p = 0.1), as well as positive surgical margins (15.5 vs. 15.7%, p = 0.7) and the nerve-sparing status (p = 0.5) were comparable between RARP and ORP. Lymph node yield (median 11 vs. 16), and median blood loss (250 vs. 700 ml) were lower at RARP (all p < 0.001). Additionally, the median operating room time was higher a...
RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VT... more RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VTE by CRSs. The rates of VTEs and median times to VTE were 6% and 74 days in Group 1, 13% and 44 days in Group 2, 15% and 40 days in Group 3, and 23% and 11 days in Group 4. Adjusted hazard ratios for VTE are shown in Table 1. Group 1 had no VTE’s or fatal pulmonary embolisms in the first 30 days after UOS. Bleeding and lymphocele rates were 0% and 2% in Group 1, 0% and 4% in Group 2, 3% and 3% in Group 3, 0% and 0% in Group 4. Complications were considered Clavien grades II-IIIa. CONCLUSIONS: VTE risk is lowest in patients who receive clinical protocol prophylaxis with EDP. Risk of VTE remains elevated for at least 90 days following UOS. A clinical VTE prevention protocol using perioperative prophylaxis and EDP is effective and safe in reducing VTE risk in UOS patients.
To evaluate the surgical performance of the new Greenlight XPS-180 W laser system (American Medic... more To evaluate the surgical performance of the new Greenlight XPS-180 W laser system (American Medical Systems, Minnetonka, MI) and the effect of prostate volume (PV), in comparison with the former HPS-120 W system, for the treatment of benign prostatic hyperplasia by photo-selective vaporization of the prostate. Between July 2007 and March 2012, 1809 patients underwent laser photo-selective vaporization of the prostate (1187 patients with the use of HPS-120 W and 622 patients with the use of XPS-180 W) at 7 international centers. All data were collected prospectively. Comparative analysis was performed between XPS and HPS according to PV measured by transrectal ultrasound. The XPS compared with HPS, allowed significantly reduced laser and operative time (29.6 minutes vs 65.8 minutes and 53 minutes vs 80 minutes, respectively; P &amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;lt;.01 for both). The number of fiber used during the procedures was significantly reduced with the XPS system (1.11 vs 2.28; P…
Introduction: Transrectal ultrasound (TRUS)-guided prostate biopsies using 18G calibre needles ar... more Introduction: Transrectal ultrasound (TRUS)-guided prostate biopsies using 18G calibre needles are widely used; most often 12-core tissue samples of the peripheral zone are obtained. Although the diagnostic yield of prostate biopsies is fair, there is still a potential for false negative results, which necessitates repeat biopsies. In an effort to improve the accuracy of prostate biopsies, different sampling schemes have been developed. One strategy has been to increase the number of core biopsies performed on each patient. Another strategy has been to improve the reliability of prostate biopsies using larger calibre needles, thereby increasing the amount of tissue obtained for each core biopsy. Methods: After approval by our institutional review board, we prospectively compared two biopsy needle sizes (18G vs. 16G) in relation to prostate cancer diagnosis, pain, bleeding and infection rates on 105 patients. Each patient underwent 6 TRUS-guided prostate biopsies with the standard 18G needle and 6 other biopsies with the experimental 16G needle. To evaluate possible complications related to the use of a larger 16G needle in the experimental group, we compared pain, bleeding and infection rates with a control group of 100 patients who underwent 12 biopsies with a single 18G needle (18G group). Pain, bleeding assessment and infection events were evaluated using patient questionnaires and telephone interviews. Results: TRUS-guided prostate biopsies using 16G calibre needles did not increase cancer detection or non-malignant pathology rate, including prostatic intraepithelial neoplasia (PIN) and atypical small acinar proliferatio (ASAP). Pain, bleeding and infectious complications were similar in both groups. Infection was defined as temperature above 38°C occurring within 48 hours after the procedure. We identified 4 patients with post-biopsy fever in the experimental (16/18G) group and 4 other patients in the (18G) control group. The post-biopsy infection rate is higher than reported just a few years ago and indicates that quinolone resistant Escherichia coli seems to be more prevalent in our urban setting than previously suspected. Limitations to our study include small group numbers. Conclusion: Larger 16G needles appear to be safe for TRUS-guided prostate biopsies. Further study in a larger, multi-institutional, prospective, randomized manner with 16G needles is warranted to assess the theoretical benefit of larger core biopsies in prostate cancer detection.
operative VTE in two groups of patients operated on by two surgeons; one who consistently used he... more operative VTE in two groups of patients operated on by two surgeons; one who consistently used heparin with SCDs (Group 1) and the other who used SCDs alone (Group 2) for prophylaxis. METHODS: An IRB approved prospectively managed database was analyzed. Group 1 received SCDs just prior to induction and 5,000 units of heparin subcutaneously just after induction. SCDs continued postoperatively and heparin was given twice a day until discharge. Group 2 maintained SCDs until ambulatory. VTE rate, patient age, BMI, operative time, lymphocele rate, estimated blood loss, and pathologic stage were compared between the two groups. Categorical variables were analyzed with chi square test of proportions and continuous variables with t-test using SPSS v 14 software. RESULTS: 1,035 consecutive patients underwent robotic prostatectomy between August 1, 2007 and September 30, 2010. 652 patients received heparin/SCDs and 383 received SCDs alone. Patient age, BMI, estimated blood loss, and pathologic stage were the same in the two groups. There was one lymphocele in each group. Although operative times were longer in Group 2 (228.0 v 165.4 min, p 0.001), the incidence of VTE was the same (0.8% v 0.8%, p .620). BMI, operative time, EBL, and the performance of lymph node dissection were not associated with VTE. CONCLUSIONS: The risk of VTE in patients undergoing robotic prostatectomy is low and not significantly reduced with the administration of prophylactic heparin/SCDs compared to SCDs alone.
urine and stone cultures as well as stone analysis for mineral content. A multivariate cumulative... more urine and stone cultures as well as stone analysis for mineral content. A multivariate cumulative logit regression model was used for statistical analysis. RESULTS: A positive correlation between UCx and SCx occurred in 109 cases (79%) and the level of discordance was similar in both the struvite, apatite (36.8% and 34.3%) but less in the non-struvite/ apatite group (24.4%). A positive SCx with negative UCx occurred in 12.5% of patients overall but occurred more commonly in the struvite and apatite groups (4, 21.1% and 5, 14.3%). Of patients presenting with positive UCx and SCx (n¼43), 13 or 30.2% (9.6% overall) had different organisms between the UCx and SCx. UCx showed no association with stone mineral content, but SCx was more frequently positive in struvite (84.2%) and apatite (65.7%) compared to non-struvite/apatite (25.6%) stones. There was not a significant correlation between stone composition and bacterial species in either UCx or SCx, there was however a 100%, 73% and 33% correlation between UCx and SCx for Enterococcus, Proteus and E.Coli respectively. CONCLUSIONS: Nearly a quarter of our patients had a positive stone culture after sterile urine or a different organism comparing stone to urine culture. When treating these infections a stone culture is essential to accurate microbial identification and antibiotic selection. Furthermore, we found that a preoperative urine culture with either enterococcus or proteus was highly predictive of the stone culture, allowing confidence in treating these infections based on UCx alone.
RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VT... more RESULTS: 484 patients had open or laparoscopic UOS, with 200 (41%) classified as high risk for VTE by CRSs. The rates of VTEs and median times to VTE were 6% and 74 days in Group 1, 13% and 44 days in Group 2, 15% and 40 days in Group 3, and 23% and 11 days in Group 4. Adjusted hazard ratios for VTE are shown in Table 1. Group 1 had no VTE's or fatal pulmonary embolisms in the first 30 days after UOS. Bleeding and lymphocele rates were 0% and 2% in Group 1, 0% and 4% in Group 2, 3% and 3% in Group 3, 0% and 0% in Group 4. Complications were considered Clavien grades II-IIIa. CONCLUSIONS: VTE risk is lowest in patients who receive clinical protocol prophylaxis with EDP. Risk of VTE remains elevated for at least 90 days following UOS. A clinical VTE prevention protocol using perioperative prophylaxis and EDP is effective and safe in reducing VTE risk in UOS patients. Incidence of thromboembolic events: multivariable Cox model Variable HR 95% CI P-value Prophylaxis 0.007 Group 3 vs. 4 0.49 (0.21-1.15) Group 2 vs. 4 0.43 (0.12-1.50) Group 1 vs. 4 0.20 (0.06-0.70) Surgery 0.50 Neph. vs. Cyst. 0.62 (0.27-1.43) Other vs. Cyst. 1.15 (0.26-5.05) Caprini Score* < 0.001 Per 1 point increase 1.33 (1.18-1.50) HR¼Hazard Ratio, CI¼confidence interval, Cyst.¼cystectomy, Neph.¼Nephrectomy. *Caprini score calculated from weighted risk factors depending on likelihood of a factor causing a VTE, uses risk factors such as age, operating room time, abnormal pulmonary function, cevtral venous access, blood transfusion, previous malignancy, current malignancy, BMI, personal or family history of VTE, and many others.
Background and Purpose: With the aging population, it is becoming increasingly important to ident... more Background and Purpose: With the aging population, it is becoming increasingly important to identify patients at risk for postsurgical complications who might be more suited for conservative treatment. We sought to identify predictors of morbidity after surgical treatment of benign prostatic hyperplasia (BPH) using a large national contemporary population-based cohort. Methods: Relying on the American College of Surgeons National Surgical-Quality Improvement Program (ACS-NSQIP; 2006-2011) database, we evaluated outcomes after transurethral resection of the prostate (TURP), laser vaporization of the prostate (LVP), and laser enucleation of the prostate (LEP). Outcomes included blood-transfusion rates, length of stay, complications, reintervention rates, and perioperative mortality. Multivariable logistic-regression analysis evaluated the predictors of perioperative morbidity and mortality. Results: Overall, 4794 (65.2%), 2439 (33.1%), and 126 (1.7%) patients underwent TURP, LVP, and LEP, respectively. No significant difference in overall complications (P = 0.3) or perioperative mortality (P = 0.5) between the three surgical groups was found. LVP was found to be associated with decreased blood transfusions (odds ratio [OR] = 0.21; P = 0.001), length of stay (OR = 0.12; P < 0.001) and reintervention rates (OR = 0.63; P = 0.02). LEP was found to be associated with decreased prolonged length of stay (OR = 0.35; P = 0.01). Men with advanced age at surgery and non-Caucasians were at increased risk of morbidity and mortality. In contrast, normal preoperative albumin and higher preoperative hematocrit (>30%) levels were the only predictors of lower overall complications and perioperative mortality. Conclusions: All three surgical modalities for BPH management were found to be safe. Advanced age and non-Caucasian race were independent predictors of adverse outcomes after BPH surgery. In patients with these attributes, conservative treatment might be a reasonable alternative. Also, preoperative hematocrit and albumin levels represent reliable predictors of adverse outcomes, suggesting that these markers should be evaluated before BPH surgery.
PURPOSE: Partial nephrectomy (PN) outcomes may be better at academic institutions than at non-aca... more PURPOSE: Partial nephrectomy (PN) outcomes may be better at academic institutions than at non-academic centers. Peer-review, sub-specialized practice profile, higher individual surgeon and institutional caseload may explain this observation. To the best of our knowledge, the role of institutional academic affiliation has not been examined with regard to PN postoperative outcomes. METHODS: Within the Health Care Utilization Project Nationwide Inpatient Sample (NIS), we focused on PNs performed within the 10 most contemporary years (1998-2007). We explored the effect of academic status on three short-term PN outcomes (intraoperative and postoperative complications, as well as in-hospital mortality). Multivariable logistic regression analyses further adjusted for age, race, gender, Charlson Comorbidity Index (CCI), surgical approach, hospital region, annual hospital caseload and insurance status. RESULTS: Overall, 8,513 PNs were identified. Of those, 5,906 (69.4%) were recorded at acad...
OBJECTIVE: Discharge patterns, including prolonged length of stay (LOS) and adverse discharge dis... more OBJECTIVE: Discharge patterns, including prolonged length of stay (LOS) and adverse discharge disposition (ADD), are important clinical indicators of quality of care. We examined the effect of several indicators on discharge patterns after radical prostatectomy (RP). METHODS: Within the Nationwide Inpatient Sample, we focused on RPs performed between 2001 and 2007. Multivariable logistic regression analyses predicting the likelihood of prolonged LOS and ADD were performed. RESULTS: Overall, 89,883 eligible RPs were identified, yielding a weighted national estimate of 442,400 eligible RPs. The rates of prolonged LOS decreased from 28.9 in the early period (2001-2003) to 14.4% in the late period (2006-2007) (P < 0.001). Similarly, the rates of ADD decreased from 7.4 in the early period to 5.0% in the late period (P < 0.001). In multivariable analyses adjusted for clustering, both annual hospital caseload (AHC) and insurance status were independent predictors of prolonged LOS and...
Background: The association of advanced age and cancer control outcomes shows discordant findings... more Background: The association of advanced age and cancer control outcomes shows discordant findings. Objective: To evaluate the effect of age on cancer control outcomes in a large population-based cohort of patients diagnosed with renal cell carcinoma (RCC) of all stages. Design, setting, and participants: Using the Surveillance Epidemiology and End Results database, 36 333 patients with RCC were identified. The population was stratified according to age: < 50, 50-59, 60-69, 70-79, and 80 yr. The effect of age on cancer control outcomes was evaluated using competing-risks regression models. Analyses were repeated stage for stage and grade for grade. Measurements: Cancer-specific mortality (CSM) was measured. Results and limitations: Age categories 50-59, 60-69, 70-79, and 80 yr respectively portended a 1.4-, 1.5-, 1.6-, and 1.9-fold higher risk of CSM than age category <50 yr (all p < 0.001). The effect of advanced age was particularly detrimental in patients with stage I disease: 1.8-, 2.3-, 3.2-, and 3.8-fold higher CSM risk for the same age groups, respectively (all p < 0.001). The effect of age on CSM was at its peak in patients with stage I, low-grade RCC (1.6-, 2.2-, 3.6-, and 4.3-fold, respectively; all p < 0.001) and remained elevated in stage I, high-grade RCC (2.2-, 2.6-, 2.4-, and 3.0-fold higher, respectively; all p < 0.05). Conversely, its effect was virtually absent in patients with stage II-IV RCC. Conclusions: Our data suggest that stage I RCC may behave in a more aggressive fashion in elderly patients. Further studies are required to confirm the current findings.
Uploads
Papers by Kevin Zorn